{
  "docId": "019de074-64e0-72b5-95dc-6b8e1900a65c",
  "docSlug": "e9cde31d37f36a409801fcfa02a89d82",
  "documentTitle": "Sarissa Capital | Activist Presentation Deck | 37 slides",
  "authorId": "sarissa-capital",
  "authorName": "Sarissa Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 37,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a 'moving goalposts' visual metaphor (soccer goals) to illustrate the shifting timeline.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-64e0-72b5-95dc-6b8e1900a65c/10",
  "deckHref": "/decks/019de074-64e0-72b5-95dc-6b8e1900a65c",
  "deckJsonHref": "/decks/019de074-64e0-72b5-95dc-6b8e1900a65c.json",
  "deckAnchorHref": "/decks/019de074-64e0-72b5-95dc-6b8e1900a65c#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.48,
        "y": 0.47
      },
      "kind": "callout",
      "text": "Amarin DEFA14A from February 6, 2023 now suggests 1Q23 approval",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f72b3cd6-60bd-4d6e-a7fd-290a4484695d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.76,
        "y": 0.65
      },
      "kind": "image",
      "text": "Moving goalposts graphic",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78d0d331-e7aa-4331-8d02-711fd7e410b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.75,
        "x": 0.08,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Amarin Full Year 2020 Earnings (February 2021): Earlier this month, regulatory authorities in China, the Chinese NMPA accepted Edding's new drug application for review of VASCEPA... near the end of 2021",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29642383-955d-43b9-a138-bf3c425e1d86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.75,
        "x": 0.08,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Amarin Full Year 2021 Earnings (March 2022): Now, an update on the already partnered international territories... Edding Pharm continues to expect to receive approval of VASCEPA in Mainland China and Hong Kong by the end of 2022",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f251b21-dfe1-4a0b-8e58-61953f0a986d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Company earnings",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8fdd58e-21a5-40da-8902-d7bb0281a13f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "The China Vascepa approval hasn't occurred as promised, now expected in 1Q23",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d67086bc-2b01-4c2c-9e2e-e596504be45a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "a334beea-5b56-4f5b-aa7f-74a5b9802f26",
      "evidence": "Contrasts historical company guidance with current reality to expose management failure.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 27,
      "from": 2,
      "beatId": "aac252d2-ccd4-496e-8536-7eabed61a932",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Monster (Amarin's failures)",
      "beatSlug": "overcoming-monster-the-monster",
      "evidence": "Slides 2-27 expose contradictions and failures of Amarin's management and board",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}